Omega-3 fatty acid supplementation does not improve maximal aerobic power, anaerobic threshold and running performance in well-trained soccer players

Scandinavian Journal of Medicine and Science in Sports

Volumn 7, Issue 1, 1997, Pages 25-31

  Raastad, T ^a   Hostmark, A T ^b   Stramme, S B ^a  

^a NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Anaerobic threshold, omega 3 fatty acids, Vo2max; Performance; Soccer

Indexed keywords

FATTY ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; ANAEROBIC THRESHOLD; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDURANCE; ERYTHROCYTE; EXERCISE; HUMAN; MALE; PHYSICAL EDUCATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RUNNING; SPORT;

ADULT; ANAEROBIC THRESHOLD; ERYTHROCYTES; EXERCISE; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FOOD, FORTIFIED; HUMANS; MALE; PHYSICAL EDUCATION AND TRAINING; PHYSICAL ENDURANCE; RUNNING; SOCCER; TRIGLYCERIDES;

EID: 0031062592     PISSN: 09057188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0838.1997.tb00113.x     Document Type: Article

References (30)

1. 2mX: a double blind randomized controlled trial in athletes. Ann Sports Med 1988: 4: 37-40.
2. Brilla LR, Landerholm TE. Effect of fish oil supplementation and exercise on serum lipids and aerobic fitness. J Sports Med Phys Fitness 1990: 30: 173-9.
3. Warner Jr JG, Ullerich IH, Albrink MJ, Yeater RA. Combined effects of aerobic exercise and omega-3 fatty acids in hyperlipidemic persons. Med Sci Sports Exer 1989: 21: 498-505.
4. Howley ET, Basset DR, Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sport Exerc 1995: 27: 1292-301.
5. Woodcock BE, Smith E, Lambert WH, Morris Jones W, Galloway JH, Greaves M, Preston FE. Benificial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J 1984: 288: 592-4.
6. Cartwright IJ, Pockley AG, Galloway JH, Greaves M, Preston FE. The effects of dietary n-3 polyunsatured fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 1985: 55: 267-81.
7. Kobayashi S, Hamazaki T, Hirai A et al. Epidemiological and clinical studies of the effects of eicosapentaenoic acid (EPA, C20:5, n-3) on blood viscosity. Clin Hemorheol 1985: 5. 493-505.
8. Helgerud J, Ingjer F, Stramme SB. Sex differences in performance-matched marathon runners. Eur J Appl Physiol 1990: 61: 433-9.
9. Ȧstrand PO, Rodahl K. Textbook of work physiology. New York: McGraw-Hill, 1986.
10. Veersteg PGA, Kippersluis GJ. Automated systems for measurements of oxygen uptake during exercise testing. Int J Sport Med 1989: 10: 107-12.
11. Berg J, Glattre E, Haldorsen T, Høstmark AT, Bay IG, Johansen AaF, Jellum E. Longchain serum fatty acids and risk of thyroid cancer. a population-based case-control study in Norway. Cancer Causes Control 1994: 5: 433-9.
12. Solvoll K, Lund-Larsen K, Søyland S, Sandstad B, Drevon CA. A quantitative food frequency questionnaire evaluated in a group of dermatologic outpatients. Scand J Nutr 1993: 37. 150-55.
13. National Research Council. Recommended dietary allowances. Washington DC: National Academy Press, 1989.
14. Gollnick PD, Saltin B. Hypothesis: significance of skeletal oxydative enzyme enhancement with endurance training. Clin Physiol 1982: 2: 1-12.
15. Buick FJ, Gledhill N. Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity. J Appl Physiol 1980: 48: 636-42.
16. Snoeckx LHEH, Abeling HFM, Lambregts JAC, Schmitz JJF, Verstappen FTJ, Renman RS. Echocardiographic dimensions in athletes in relation to their training programs. Med Sci Sports Exerc 1982: 14: 428-34.
17. Ernst E, Matrai A, Aschenbrenner E. Blood rheology in athletes. J Sports Med 1985: 25: 207-10.
18. Charm SE, Paz H. Kurland GS. Reduced plasma viscosity among joggers compared with non-joggers. Biorheology 1979. 16: 185-9.
19. Lechter RL, Pickering TG, Chien S, et al. Effects of exercise on plasma viscosity in athletes and sedentary normal subjects. Clin Cardiol 1981: 4: 172-9.
20. Ernst E. Changes in blood rheology produced by exercise. JAMA 1985: 20: 2962.
21. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991.
22. von Schacky C, Fisher S, Weber PC. Long-term effects of dietary marine n-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 1985: 76: 1626-31.
23. Sanders TA. B, Hinds A. The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers. Br J Nutr 1992: 68: 163-73.
24. Flaten H, Høstmark AT, Kierulf P. Effects of fish oil concentrate on plasma fibrinogen, plasminogen activator inhibitor and serum lipids. J Opt Nutr 1993. 2: 73-81.
25. Dyerberg J, Berg Shmidt E. The effect of fish oil on cardiovascular risk markers. In: Drevon CA, Baksaas I, Krokan HE, ed. Omega-3 fatty acids. Metabolism and biological effects. Basel/Switzerland: Birkhäser verlag, 1993: 163-72.
26. Bittolo-Bon G, Cazzolato G, Alessandrini P, Soldan S, Casalino G, Avogaro P. Effects of concentrated DHA and EPA supplementation on LDL peroxidation and vitamin E status in type lib hyperlipedemic patients. In: Drevon C.A, Baksaas I, Krokan HE, ed. Omega-3 fatty acids. Metabolism and biological effects. Basel/Switzerland. Birkhäser verlag, 1993: 51-8.
27. Connor WE, DeFrancesco CA, Connor SL. N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglycerdemic patients. Ann NY Acad Sci 1993: 683: 16-34.
28. Landmark K, Thaulow E, Hysing J, Mundal HH. Eritsland J, Hjermann I. Effects of fish oil, nifedipine and their combination on blood pressure and lipids in primary hypertension. J Hum Hypertens 1993: 7: 25-32.
29. Harris WS, Connor WE, Illingworth DA, Rothrock DM, Foster DM. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 1990: 31: 1549-58.
30. Willumsen N, Hexeberg S, Skorve J, Lundquist M, Berge RK. Docosahexaenoic acid shows no triglyseride lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J Lipid Res 1993: 34: 13-22.